Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy

by Nadia A. Nabulsi, Michelle T. Martin, Michelle T. Martin, Lisa K. Sharp, David E. Koren, Robyn Teply, Autumn Zuckerman, Todd A. Lee
Published 2020-11-01

Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center

by David E. Koren PharmD, Volodymyra Fedkiv PharmD, Huaqing Zhao PhD, Geena Kludjian PharmD, Robert L. Bettiker MD, Ellen Tedaldi MD, Rafik Samuel MD
Published 2020-12-01